Your doctor will likely suggest psoriasis treatment creams, lotions, foams, sprays, solutions, and ointments. These are called topical treatments – meaning you put them directly on your skin or ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of Dermatology/National Psoriasis ...

Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...

While there is no cure for psoriasis, your healthcare provider will likely suggest a combination of treatments to help you better manage your condition. Topical treatments, or ointments that you ...

A 40-year-old Hispanic man presented for treatment of dermatitis on his elbows ... A clinical diagnosis was made of psoriasis and he was prescribed clobetasol propionate ointment with salicylic ...

Roflumilast, a topical phosphodiesterase 4 (PDE4) inhibitor, was approved for the treatment of plaque psoriasis in adults and adolescents in 2022, and in children aged 6 years or up in 2023.

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

ZORYVE foam is a once-daily, steroid-free topical and is now widely available as a treatment for plaque psoriasis. Nearly 9 million people in the United States are living with plaque psoriasis ...

Psoriasis is a chronic inflammatory disorder for which phosphodiesterase-4 (PDE4) inhibitors have emerged as promising therapeutic agents due to an ability to regulate inflammatory signaling pathways.